The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Lymphocyte Oxidative DNA Damage and Plasma Antioxidants in Alzheimer Disease
Abstract
CONTEXT: A large body of experimental evidence suggests that in Alzheimer disease (AD) pathogenesis an important role is played by oxidative stress, but there is still a lack of data on in vivo markers of free radical-induced damage. OBJECTIVES: To evaluate levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative damage to DNA, in peripheral lymphocytes; to measure plasma concentrations of several nonenzymatic antioxidants; and to assess the relationships between any observed changes in lymphocyte DNA 8-OHdG content and plasma antioxidant levels in patients with AD and healthy aged control subjects. SUBJECTS: Forty elderly outpatients with AD and 39 healthy age- and sex-matched controls were studied. MAIN OUTCOME MEASURES: The level of 8-OHdG was determined in DNA extracted from lymphocytes and plasma levels of vitamin C, vitamin A, vitamin E, and carotenoids (zeaxanthin, beta-cryptoxanthin, lycopene, lutein, and alpha- and beta-carotene) were measured by high-performance liquid chromatography. RESULTS: Lymphocyte DNA 8-OHdG content was significantly higher and plasma levels of antioxidants (with the exception of lutein) were significantly lower in patients with AD compared with controls. In patients with AD, a significant inverse relationship between lymphocyte DNA 8-OHdG content and plasma levels of lycopene, lutein, alpha-carotene, and beta-carotene, respectively, was observed. CONCLUSIONS: Markers of oxidative damage are increased in AD and correlate with decreased levels of plasma antioxidants. These findings suggest that lymphocyte DNA 8-OHdG content in patients with AD reflects a condition of increased oxidative stress related to a poor antioxidant status.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, several nonenzymatic antioxidants such as vitamin C, vitamin A, vitamin E, and carotenoids were lower in the plasma of patients with AD compared with controls and are associated to increased levels of oxidative damage markers [155].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [155]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Guigoz, Y., Vellas, B. J., & Garry, P. J. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1996.tb03793.x · Cited by 1,559
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,434
Oxidative stress and Alzheimer disease
Christen, Y. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.621s · Cited by 1,176
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037
Self-citationOxidative Stress: Introductory Remarks
Sies, H. (1985) · Elsevier eBooks · doi:10.1016/b978-0-12-642760-8.50005-3 · Cited by 1,037
Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777
Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain
Mecocci, P., MacGarvey, U., Kaufman, A. E., Koontz, D., Shoffner, J. M., Wallace, D. C., & Beal, M. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340416 · Cited by 757
Self-citationCytochrome oxidase deficiency in Alzheimer’s disease
Parker, W. D., Filley, C. M., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1302 · Cited by 598
Cited by
Sorted by citations
The role of antioxidants in the chemistry of oxidative stress: A review
Pisoschi, A. M., & Pop, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.040 · Cited by 2,963
The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates
Franceschi, C., Garagnani, P., Morsiani, C., Conte, M., Santoro, A., Grignolio, A., Monti, D., Capri, M., & Salvioli, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00061 · Cited by 945
Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview
Mariani, E., Polidori, M. C., Cherubini, A., & Mecocci, P. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.04.023 · Cited by 691
Self-citationPlasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease
Rinaldi, P., Polidori, M. C., Metastasio, A., Mariani, E., Mattioli, P., Cherubini, A., Catani, M., Cecchetti, R., Senin, U., & Mecocci, P. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00031-9 · Cited by 571
Self-citationOxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease
Lovell, M. A., & Markesbery, W. R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm821 · Cited by 515
The chemistry of Alzheimer’s disease
Rauk, A. (2009) · Chemical Society Reviews · doi:10.1039/b807980n · Cited by 417
Smith, M. A., Zhu, X., Tabaton, M., Liu, G., McKeel, D. W., Cohen, M. L., Wang, X., Siedlak, S. L., Dwyer, B. E., Hayashi, T., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1239 · Cited by 406
Ayaz, M., Sadiq, A., Junaid, M., Ullah, F., Ovais, M., Ullah, I., Ahmed, J., & Shahid, M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00155 · Cited by 320
Oxidative stress in Alzheimer's disease
Chauhan, V. P. S., & Chauhan, A. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.004 · Cited by 349
Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis
Schrag, M., Mueller, C., Zabel, M. K., Crofton, A. R., Kirsch, W. M., Ghribi, O., Squitti, R., & Perry, G. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.005 · Cited by 342
Choi, D., Lee, Y., Hong, J. T., & Lee, H. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.014 · Cited by 311
Marzia Perluigi, A., Domenico, F. D., & Butterfield, D. A. (2023) · Physiological Reviews · doi:10.1152/physrev.00030.2022 · Cited by 322
Johnson, E. J., Vishwanathan, R., Johnson, M. A., Hausman, D. B., Davey, A., Scott, T. M., Green, R. C., Miller, L. S., Gearing, M., Woodard, J. L., et al. (2013) · Journal of Aging Research · doi:10.1155/2013/951786 · Cited by 268
Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients
Migliore, L., Fontana, I., Trippi, F., Colognato, R., Coppedè, F., Tognoni, G., Nucciarone, B., & Siciliano, G. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.016 · Cited by 266
Mecocci, P., Boccardi, V., Cecchetti, R., Bastiani, P., Scamosci, M., Ruggiero, C., & Baroni, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170732 · Cited by 259
Self-citationNicastrin, Presenilin, APH-1, and PEN-2 Form Active γ-Secretase Complexes in Mitochondria
Hansson, C. A., Frykman, S., Farmery, M. R., Tjernberg, L. O., Nilsberth, C., Pursglove, S. E., Ito, A., Winblad, B., Cowburn, R. F., Thyberg, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404500200 · Cited by 256
Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment
Mangialasche, F., Polidori, M. C., Monastero, R., Ercolani, S., Camarda, C., Cecchetti, R., & Mecocci, P. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.04.002 · Cited by 250
Self-citationMild Cognitive Impairment: A Systematic Review
Mariani, E., Monastero, R., & Mecocci, P. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12104 · Cited by 248
Self-citationBeneficial effects and potential risks of tomato consumption for human health: An overview
Salehi, B., Sharifi‐Rad, R., Sharopov, F. S., Namieśnik, J., Roointan, A., Kamle, M., Kumar, P., Martins, N. A., & Sharifi‐Rad, J. (2019) · Nutrition · doi:10.1016/j.nut.2019.01.012 · Cited by 246
Peripheral Oxidative Stress Biomarkers in Mild Cognitive Impairment and Alzheimer's Disease
Torres, L. H., Quaglio, N. B., de Souza, G. T., Garcia, R. C. T., Dati, L. M. M., Moreira, W. L., Loureiro, A. P. D. M., Souza‐Talarico, J. N., Smid, J., Porto, C. S., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110284 · Cited by 239
Nutritional Quality and Health Benefits of Vegetables: A Review
Dias, J. S. (2012) · Food and Nutrition Sciences · doi:10.4236/fns.2012.310179 · Cited by 239
Lafay‐Chebassier, C., Paccalin, M., Page, G., Barc‐Pain, S., Perault‐Pochat, M. C., Gil, R., Pradier, L., & Hugon, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03187.x · Cited by 211
Functional Properties of Carotenoids in Human Health
Perera, C. O., & Yen, G. M. (2007) · International Journal of Food Properties · doi:10.1080/10942910601045271 · Cited by 214
Mitochondrial dysfunction, oxidative stress and neurodegeneration
Mancuso, M., Coppedè, F., Migliore, L., Siciliano, G., & Murri, L. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10110 · Cited by 212
A possible role for lutein and zeaxanthin in cognitive function in the elderly
Johnson, E. J. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.034611 · Cited by 207
DNA damage in neurodegenerative diseases
Coppedè, F., & Migliore, L. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.11.010 · Cited by 202
Mitochondrial genes are altered in blood early in Alzheimer's disease
Lunnon, K., Keohane, A., Pidsley, R., Newhouse, S., Riddoch-Contreras, J., Thubron, E. B., Devall, M., Soininen, H., Kłoszewska, I., Mecocci, P., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.029 · Cited by 190
Self-citationLutein as a Modulator of Oxidative Stress-Mediated Inflammatory Diseases
Ahn, Y. J., & Kim, H. (2021) · Antioxidants · doi:10.3390/antiox10091448 · Cited by 190
Biomaterial Scaffold Fabrication Techniques for Potential Tissue Engineering Applications
Subia, B., Kundu, S. C., & C., S. (2010) · InTech eBooks · doi:10.5772/8581 · Cited by 193
Transcriptional profiling of Alzheimer blood mononuclear cells by microarray
Maes, O. C., Xu, S., Yu, B., Chertkow, H. M., Wang, E., & Schipper, H. M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.004 · Cited by 186
Evidence for defective retinoid transport and function in late onset Alzheimer's disease
Goodman, A. B., & Pardee, A. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437937100 · Cited by 184
Buccellato, F. R., D’Anca, M., Fenoglio, C., Scarpini, E., & Galimberti, D. (2021) · Antioxidants · doi:10.3390/antiox10091353 · Cited by 179
Vascular oxidative stress in Alzheimer disease
Zhu, X., Smith, M. A., Honda, K., Aliev, G., Moreira, P. I., Nunomura, A., Casadesús, G., Harris, P. L. R., Siedlak, S. L., & Perry, G. L. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.039 · Cited by 175
The Effectiveness of Vitamin E Treatment in Alzheimer’s Disease
Lloret, A., Esteve, D., Monllor, P., Cervera‐Ferri, A., & Lloret, Á. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040879 · Cited by 165
Lorenzo, Y., Azqueta, A., Luna, L., Bonilla, F., Dominguez, G., & Collins, A. R. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn270 · Cited by 159
Ferreiro, E. B., Baldeiras, I., Ferreira, I. L., Costa, R. O., Rego, A. C., Pereira, C., & Oliveira, C. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/735206 · Cited by 156
DNA Oxidation in Alzheimer's Disease
Markesbery, W. R., & Lovell, M. A. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2039 · Cited by 151
Lutein: A Valuable Ingredient of Fruit and Vegetables
Calvo, M. M. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690590957034 · Cited by 152
DNA Damage and Repair in Alzheimers Disease
Coppede, F., & Migliore, L. (2009) · Current Alzheimer Research · doi:10.2174/156720509787313970 · Cited by 148
Tomato Consumption and Health: Emerging Benefits
Burton‐Freeman, B. M., & Reimers, K. J. (2010) · American Journal of Lifestyle Medicine · doi:10.1177/1559827610387488 · Cited by 147
Oxidative Imbalance in Alzheimer's Disease
Zhu, X., Lee, H., Casadesús, G., Ávila, J., Drew, K. L., Perry, G. L., & Smith, M. A. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:205 · Cited by 146
The relation between psychological factors and DNA-damage: A critical review
Gidron, Y., Russ, K. M., Tissarchondou, H. S., & Warner, J. A. (2006) · Biological Psychology · doi:10.1016/j.biopsycho.2005.11.011 · Cited by 149
Dietary antioxidants and beneficial effect on oxidatively damaged DNA
Möller, P., & Loft, S. H. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.04.001 · Cited by 144
Chang, Y., Chang, W., Tsai, N., Huang, C., Kung, C., Su, Y., Lin, W.-C., Cheng, B., Su, C.-M., Chiang, Y.-F., et al. (2014) · BioMed Research International · doi:10.1155/2014/182303 · Cited by 145
Why is the amyloid beta peptide of Alzheimer’s disease neurotoxic?
Rauk, A. (2008) · Dalton Transactions · doi:10.1039/b718601k · Cited by 139
Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease
Zana, M., Janka, Z., & Kalman, J. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.008 · Cited by 140
Migliore, L., Fontana, I., Colognato, R., Coppedè, F., Siciliano, G., & Murri, L. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.10.002 · Cited by 149
Polidori, M. C., Mattioli, P., Aldred, S., Cecchetti, R., Stahl, W., Griffiths, H. R., Senin, U., Sies, H., & Mecocci, P. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000080027 · Cited by 135
Self-citationMolecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease
Uddin, M. S., Kabir, M. T., Niaz, K., Jeandet, P., Clément, C., Mathew, B., Rauf, A., Rengasamy, K. R. R., Sobarzo‐Sánchez, E., Ashraf, G. M., et al. (2020) · Molecules · doi:10.3390/molecules25061267 · Cited by 135
Vitamin E in Neurodegenerative Disorders: Alzheimer's Disease
Kontush, A., & Schekatolina, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1331.025 · Cited by 132
Akbaraly, N. T., Faure, H., Gourlet, V., Favier, A., & Berr, C. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.3.308 · Cited by 130
Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases
Shadfar, S., Parakh, S., Jamali, M. S., & Atkin, J. D. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00350-4 · Cited by 148
Peripheral Mitochondrial Dysfunction in Alzheimer’s Disease: Focus on Lymphocytes
Leuner, K., Schulz, K. L., Schuett, T., Pantel, J., Prvulovic, D., Rhein, V. F., Savaskan, E., Czech, C., Eckert, A., & Müller, W. E. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8300-y · Cited by 127
Serum Lycopene, Lutein and Zeaxanthin, and the Risk of Alzheimer's Disease Mortality in Older Adults
Min, J., & Min, K. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000356486 · Cited by 124
Biomarkers in Alzheimer's disease drug development
Cummings, J. L. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.06.004 · Cited by 122
Honarvar, N. M., Saedisomeolia, A., Abdolahi, M., Shayeganrad, A., Sangsari, G. T., Rad, B. H., & Muench, G. W. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0857-x · Cited by 123
Wang, W., Shinto, L. H., Connor, W. E., & Quinn, J. F. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13103 · Cited by 120
Carotenoids and Alzheimer’s Disease: An insight into therapeutic role of retinoids in animal models
Obulesu, M., Dowlathabad, M. R., & Bramhachari, P. V. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.04.004 · Cited by 116
Vitamin E and Alzheimer’s disease: what do we know so far?
Browne, D., McGuinness, B., Woodside, J. V., & McKay, G. J. (2019) · Clinical Interventions in Aging · doi:10.2147/cia.s186760 · Cited by 119
Sultana, R., Mecocci, P., Mangialasche, F., Cecchetti, R., Baglioni, M., & Butterfield, D. A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101425 · Cited by 111
Self-citationOxidative stress in Alzheimer's disease
Gibson, G. E., & Huang, H. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.017 · Cited by 110
Ni, W., Huang, Y., Wang, X., Zhang, J., & Wu, K. (2013) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2013.11.032 · Cited by 109
Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease
Blandini, F., Sinforiani, E., Pacchetti, C., Samuele, A., Bazzini, E., Zangaglia, R., Nappi, G., & Martignoni, E. (2006) · Neurology · doi:10.1212/01.wnl.0000198511.09968.b3 · Cited by 106
Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice
Schüssel, K., Frey, C., Jourdan, C., Keil, U., Weber, C. C., Müller-Spahn, F., Müller, W. E., & Eckert, A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.041 · Cited by 94
Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment
Beal, M. F. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.022 · Cited by 94
Treatment of Alzheimer’s Disease with a Cholinesterase Inhibitor Combined with Antioxidants
Cornelli, U. (2010) · Neurodegenerative Diseases · doi:10.1159/000295663 · Cited by 90
The oxidative damage theory of aging
Lin, M. T., & Flint Beal, M. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00007-0 · Cited by 89
Blood markers of oxidative stress in A lzheimer's disease
Skoumalová, A., & Hort, J. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01585.x · Cited by 93
Corte, L., Rellini, P., Roscini, L., Fatichenti, F., & Cardinali, G. (2009) · Analytica Chimica Acta · doi:10.1016/j.aca.2009.11.035 · Cited by 87
A review of genome mutation and Alzheimer's disease
Thomas, P., & Fenech, M. F. (2006) · Mutagenesis · doi:10.1093/mutage/gel055 · Cited by 88
Mitochondrial Abnormalities in Alzheimer’s Disease
Silva, D. F., Selfridge, J. E., Lu, J., E, L., Cardoso, S. M., & Swerdlow, R. H. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00003-9 · Cited by 86
Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD
Qiu, C., Winblad, B. G., Fastbom, J., & Fratiglioni, L. (2003) · Neurology · doi:10.1212/wnl.61.5.655 · Cited by 83
Vitamin E: How much is enough, too much and why!
Traber, M. G., & Head, B. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.10.028 · Cited by 86
Peripheral Chemo-Cytokine Profiles in Alzheimers and Parkinsons Diseases
Reale, M., Greig, N., & Kamal, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709789055199 · Cited by 82
The protective role of plant biophenols in mechanisms of Alzheimer's disease
Omar, S. H., Scott, C., Hamlin, A. S., & Obied, H. K. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.016 · Cited by 84
Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer’s disease
Polidori, M. C., Griffiths, H. R., Mariani, E., & Mecocci, P. (2007) · Amino Acids · doi:10.1007/s00726-006-0431-x · Cited by 80
Self-citationOxidative challenge in Alzheimer's disease: state of knowledge and future needs
Cervellati, C., Wood, P. L., Romani, A., Valacchi, G., Squerzanti, M., Sanz, J. M., Ortolani, B., & Zuliani, G. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2015-000017 · Cited by 75
Leuner, K., Pantel, J., Frey, C., Schindowski, K., Schulz, K. L., Wegat, T., Maurer, K., Eckert, A., & Müller, W. E. G. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_27 · Cited by 74
A Review of Oxidative Stress Products and Related Genes in Early Alzheimer’s Disease
Cioffi, F., Adam, R. H. I., Bansal, R., & Broersen, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210497 · Cited by 73
Lee, S. H., Kim, I., & Chung, B. C. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.11.021 · Cited by 77
Oxidative stress in mild cognitive impairment and Alzheimer disease: A continuum
Mecocci, P. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6207 · Cited by 70
Self-citationLeandro, G. D. S., Evangelista, A. F., Lôbo, R. R., Xavier, D. J., Moriguti, J. C., & Sakamoto‐Hojo, E. T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170205 · Cited by 67
Amyloid-β Metal Interaction and Metal Chelation
Cuajungco, M. P., Frederickson, C. J., & Bush, A. I. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_12 · Cited by 68
Biochemical Markers and Risk Factors of Alzheimers Disease
Flirski, M., & Sobów, T. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772704 · Cited by 67
Association of Oxidative Stress–Induced Nucleic Acid Damage With Psychiatric Disorders in Adults
Jørgensen, A., Baago, I. B., Rygner, Z., Jørgensen, M. B., Andersen, P. K., Kessing, L. V., & Poulsen, H. E. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.2066 · Cited by 63
Sultana, R., Baglioni, M., Cecchetti, R., Cai, J., Klein, J. B., Bastiani, P., Ruggiero, C., Mecocci, P., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.001 · Cited by 64
Self-citationA quantitative meta-analysis of vitamin C in the pathophysiology of Alzheimer’s disease
Hamid, M., Mansoor, S., Amber, S., & Zahid, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.970263 · Cited by 67
Mullan, K., Cardwell, C. R., McGuinness, B., Woodside, J. V., & McKay, G. J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170758 · Cited by 64
Facheris, M., Beretta, S., & Ferrarese, C. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6210 · Cited by 61
Yuan, C., Fondell, E., Ascherio, A., Okereke, O. I., Grodstein, F., Albert Hofman, D., & Willett, W. C. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa087 · Cited by 64
Urinary 8-hydroxy-2′-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer’s disease
Zengi, O., Karakaş, A., Ergün, U., Şeneş, M., İnan, L. E., & Yücel, D. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.792 · Cited by 60
Kelly, D., Coen, R. F., Akuffo, K. O., Beatty, S., Dennison, J. L., Moran, R., Stack, J., Howard, A. N., Mulcahy, R., & Nolan, J. M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150199 · Cited by 57
Prevention of Cognitive Decline in Alzheimer’s Disease by Novel Antioxidative Supplements
Tadokoro, K., Ohta, Y., Inufusa, H., Loon, A. F. N., & Abe, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061974 · Cited by 58
Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and Prognostics
Dhauria, M., Mondal, R., Deb, S., Shome, G., Chowdhury, D., Sarkar, S., & Benito‐León, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010911 · Cited by 62
Koide, S., Kinoshita, Y., Ito, N., Kimura, J., Yokoyama, K., & Karube, I. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.06.015 · Cited by 56
Inflammatory Process and Molecular Targets for Antiinflammatory Nutraceuticals
Huang, M., Ghai, G. R., & Ho, C. (2004) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/j.1541-4337.2004.tb00063.x · Cited by 57
Antioxidants for the treatment of mild cognitive impairment
Mecocci, P., Mariani, E., Cornacchiola, V., & Polidori, M. C. (2004) · Neurological Research · doi:10.1179/016164104225017659 · Cited by 55
Self-citationLipophilic antioxidants in neurodegenerative diseases
Chang, K., Cheng, M., Chiang, M.-C., & Chen, C. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.06.031 · Cited by 59
Mangialasche, F., Baglioni, M., Cecchetti, R., Kivipelto, M., Ruggiero, C., Piobbico, D., Kussmaul, L., Monastero, R., Brancorsini, S., & Mecocci, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142052 · Cited by 53
Self-citationCoppedè, F., & Migliore, L. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1415 · Cited by 53
Metadata
- Authors
- Mecocci, P.
- Affiliations
- University of Perugia (IT)
- Corresponding author
- Mecocci, Patrizia
- ORCID
- Mecocci, Patrizia
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2002-05-01
- Volume
- 59
- Issue
- 5
- Pages
- 794
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2130940521
- Cited by
- 229
- References
- 53
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 11 · 2023: 4 · 2022: 9 · 2021: 9 · 2020: 7 · 2019: 9 · 2018: 9 · 2017: 5 · 2016: 8 · 2015: 6 · 2014: 7 · 2013: 15 · 2012: 8
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, oxidative stress, 8-hydroxy-2'-deoxyguanosine, lymphocyte DNA damage, plasma antioxidants, carotenoids, lycopene, lutein, vitamin C, vitamin E, vitamin A, oxidative damage, biomarkers
- MeSH terms
- 8-Hydroxy-2'-Deoxyguanosine, Aged, Aged, 80 and over, Alzheimer Disease, Antioxidants, Deoxyguanosine, DNA Damage, Female, Humans, Lymphocytes, Male, Oxidation-Reduction, Linear Models, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review